Up-Regulation of Drug Resistance-Related Vaults During Dendritic Cell Development1
暂无分享,去创建一个
E. Wiemer | T. D. de Gruijl | G. Scheffer | R. Scheper | T. Rustemeyer | A. Reurs | M. C. de Jong | A. B. Schroeijers | A. Stam
[1] E. Wiemer,et al. Detection of the Mr 110,000 Lung Resistance-related Protein LRP/MVP with Monoclonal Antibodies , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[2] O. Fardel,et al. Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. , 2001, Human immunology.
[3] G. Woods,et al. Evidence that natural killer cells express mini P‐glycoproteins but not classic 170 kDa P‐glycoprotein , 2001, British journal of haematology.
[4] A. Osterhaus,et al. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. , 2000, Vaccine.
[5] D. Jäger,et al. The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes , 2000, Cell.
[6] V. Kickhoefer,et al. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines. , 2000, Cancer research.
[7] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[8] A. Harris,et al. Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assay , 1999, British Journal of Cancer.
[9] S. Takao,et al. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. , 1999, Journal of the National Cancer Institute.
[10] P. Stewart,et al. Structure of the vault, a ubiquitous celular component. , 1999, Structure.
[11] L. Rome,et al. Recombinant Major Vault Protein Is Targeted to Neuritic Tips of PC12 Cells , 1999, The Journal of cell biology.
[12] G. Piluso,et al. Interaction of Vault Particles with Estrogen Receptor in the MCF-7 Breast Cancer Cell , 1998, The Journal of cell biology.
[13] R. Steinman,et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] V. Kickhoefer,et al. Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines* , 1998, The Journal of Biological Chemistry.
[15] G. Donelli,et al. Intracellular expression of P-170 glycoprotein in peripheral blood mononuclear cell subsets from healthy donors and HIV-infected patients. , 1998, Haematologica.
[16] T. Tsuruo,et al. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Hart,et al. Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.
[18] K. Suprenant,et al. Characterization of the sea urchin major vault protein: a possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport. , 1997, Developmental biology.
[19] K. Kliche,et al. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. , 1997, Blood.
[20] R. Kellner,et al. The Major Vault Protein (MVP100) Is Contained in Cholinergic Nerve Terminals of Electric Ray Electric Organ* , 1996, The Journal of Biological Chemistry.
[21] U. Germann,et al. P-glycoprotein--a mediator of multidrug resistance in tumour cells. , 1996, European journal of cancer.
[22] L. Rome,et al. Dictyostelium Vaults: Disruption of the Major Proteins Reveals Growth and Morphological Defects and Uncovers a New Associated Protein (*) , 1995, The Journal of Biological Chemistry.
[23] H. Clevers,et al. The drug resistance-related protein LRP is the human major vault protein , 1995, Nature Medicine.
[24] L. Pilarski,et al. Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment. , 1995, Leukemia & lymphoma.
[25] M. Willingham,et al. P‐glycoprotein epitope mapping. I. Identification of a linear human‐specific epitope in the fourth loop of the P‐glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi‐drug‐resistant cells , 2007, International journal of cancer.
[26] A. Molinari,et al. P‐glycoprotein expression in the Golgi apparatus of multidrug‐resistant cells , 1994, International journal of cancer.
[27] N. Kedersha,et al. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. , 1993, Journal of cell science.
[28] M. Slovak,et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. , 1993, Cancer research.
[29] F. Baas,et al. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. , 1993, Cancer research.
[30] I. Roninson,et al. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Chugani,et al. Unlocking vaults: organelles in search of a function. , 1991, Trends in cell biology.
[32] L. Rome,et al. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes , 1990, The Journal of cell biology.
[33] J. Gariépy,et al. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Bulte,et al. Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistance , 1988, International journal of cancer.
[35] N. Mulder,et al. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. , 1987, Cancer research.
[36] T. Tsuruo,et al. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. , 1986, Proceedings of the National Academy of Sciences of the United States of America.